An experimental tablet treatment for child diabetes, where youngsters have traditionally had to inject themselves with sugar controlling insulin, could end up eradicating the disease altogether, according to the scientist leading the European NAIMIT project.
‘We will see the day in the not-too-distant future when we’ll eradicate the disease completely,’ said Professor Chantal Mathieu, based at the University of Leuven in Belgium.
The treatment was originally devised as a way to control the progression of the disease without using injections.
Type-1 diabetes, traditionally termed ‘juvenile diabetes’ because a majority of cases were in children, also affects adults and usually requires that the sufferer injects themselves with insulin several times each day as their body often stops being able to produce the blood sugar controlling hormone.
So far, the new treatment has been tested on mice, but Prof. Mathieu believes it will soon start benefiting youngsters.
‘The first tests on humans will start very shortly,’ she said.
Type-1 diabetes affects about two million people in the European Union and it is growing at a rate of about 3 % per year. It is often caused by genetic susceptibility, unlike the most common form of the disease, known as Type-2 diabetes, which can results from a lifestyle of unhealthy food and lack of exercise.
An air quality study has for the first time detected nano-sized particles of air pollution in children’s urine. With a diameter of just 100 nanometers - a thousandth of the width of a human hair - these ultrafine particles are the smallest particles found in air pollution and have been linked to heart disease and respiratory conditions in previous studies.
There are many rare genetic diseases that strike perhaps only one in a million people. Often incurable, they can be profoundly debilitating and frequently life-threatening. Though each particular disease is rare, they number in the thousands – which means that together they affect about 30 million Europeans or around 7% of us. Treating these diseases is challenging and until recently, no cure was thought to be even possible for most of them. Now, hopes are rising for people living with rare genetic diseases as new treatments are being developed.
Global warming is a reality – but just how bad will it be? A study published in January 2018 claims to halve the uncertainty around how much our planet's temperature will change in response to rising carbon dioxide (CO2) levels, potentially giving governments more confidence to prepare for the future.
Crimes that involve chemical, biological, radiological or nuclear (CBRN) materials pose a deadly threat not just to the target of the attack but to innocent bystanders and police investigators. Often, these crimes may involve unusual circumstances or they are terrorist-related incidents, such as an assassination attempt or the sending of poisons through the mail.
A new analysis all but rules out the best and worst warming scenarios – but not everyone believes it.
Remote-sensing tech paves the way for police and first responders.
'Moonshots' could energise Europe's science funding and make Europe cool again, says innovation expert Prof. Mazzucato in a new report.